ensifentrine

^[1]

Indications

↑ Anzueto A, Barjaktarevic IZ, Siler TM et al Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo- controlled, Multicenter Phase III Trials (the ENHANCE Trials). Am J Respir Crit Care Med. 2023 Aug 15;208(4):406-416. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37364283 PMCID: PMC10449067 Free PMC article